How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?

ABSTRACT:

SUBMITTER: Meisen WH 

PROVIDER: S-EPMC5298807 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature